Literature DB >> 14686959

Obesity in the Caribbean: the Jamaican experience.

D Ragoobirsingh1, E Y St A Morrison, P Johnson, E Lewis-Fuller.   

Abstract

AIM: This study was designed to investigate the point prevalence and pattern of obesity in the Jamaican adult population.
METHODS: A two-stage-stratified random sampling design was used, and individuals aged 15 years and over were interviewed. In addition, anthropometric measurements were performed. The data were analysed using the SPSS statistical software version 8. Non-response was documented and factored into the final analysis of the survey data.
RESULTS: A total of 2105 individuals responded to the all island survey, with 69% being females. Truncal obesity and gynoid obesity showed similar prevalence data. Both were affected by increasing age, being female, level of education attained and smoking status.
CONCLUSIONS: Jamaica has a point prevalence of obesity, truncal 36.2% and gynoid 34.1%, in the 15 and over age group.

Entities:  

Mesh:

Year:  2004        PMID: 14686959     DOI: 10.1111/j.1463-1326.2004.00303.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  3 in total

1.  Dyslipidaemia in hypertensive obese type 2 diabetic patients in Jamaica.

Authors:  Lorenzo Gordon; Dalip Ragoobirsingh; Errol Morrison; Donovan McGrowder; Eric Choo-Kang; E Martorell
Journal:  Arch Med Sci       Date:  2010-10-26       Impact factor: 3.318

2.  10-year trends in noncommunicable disease mortality in the Caribbean region.

Authors:  Hilda Razzaghi; Damali N Martin; Sarah Quesnel-Crooks; Yuling Hong; Edward Gregg; Glennis Andall-Brereton; Vilma Gawryszweski; Mona Saraiya
Journal:  Rev Panam Salud Publica       Date:  2019-03-27

3.  A cross-sectional study of Jamaican adolescents' risk for type 2 diabetes and cardiovascular diseases.

Authors:  Sheila C Barrett; Fatma G Huffman; Paulette Johnson; Adriana Campa; Marcia Magnus; Dalip Ragoobirsingh
Journal:  BMJ Open       Date:  2013-07-11       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.